Teva And Trump Administration Commit To Lowering Select Medicaid Drug Costs
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced a shared commitment with the Trump Administration to lower the cost of select medicines for American
Teva, a drug company, is working with the government to make some medicines cheaper for people on Medicaid (help-pay healthcare). This shows the company wants to work with leaders, but it might also mean their profits could be smaller.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.